annual operating expenses:
$33.86B+$5.04B(+17.49%)Summary
- As of today (August 30, 2025), AZN annual total operating expenses is $33.86 billion, with the most recent change of +$5.04 billion (+17.49%) on December 31, 2024.
- During the last 3 years, AZN annual operating expenses has risen by +$8.74 billion (+34.81%).
- AZN annual operating expenses is now at all-time high.
Performance
AZN Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$7.54B+$835.21M(+12.45%)Summary
- As of today (August 30, 2025), AZN quarterly total operating expenses is $7.54 billion, with the most recent change of +$835.21 million (+12.45%) on June 30, 2025.
- Over the past year, AZN quarterly operating expenses has increased by +$588.21 million (+8.46%).
- AZN quarterly operating expenses is now -5.43% below its all-time high of $7.97 billion, reached on December 31, 2024.
Performance
AZN quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AZN Operating expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +17.5% | +8.5% |
3 y3 years | +34.8% | +23.9% |
5 y5 years | +91.0% | +83.8% |
AZN Operating expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +34.8% | -5.4% | +37.1% |
5 y | 5-year | at high | +94.6% | -5.4% | +83.8% |
alltime | all time | at high | +565.3% | -5.4% | +3807.4% |
AZN Operating expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $7.54B(+12.5%) |
Mar 2025 | - | $6.71B(-15.9%) |
Dec 2024 | $33.86B(+17.5%) | $7.97B(+16.3%) |
Sep 2024 | - | $6.86B(-1.4%) |
Jun 2024 | - | $6.95B(+10.5%) |
Mar 2024 | - | $6.29B(-15.5%) |
Dec 2023 | $28.82B(+5.0%) | $7.45B(+16.4%) |
Sep 2023 | - | $6.40B(-4.1%) |
Jun 2023 | - | $6.67B(+21.4%) |
Mar 2023 | - | $5.50B(-9.3%) |
Dec 2022 | $27.45B(+9.3%) | $6.06B(+5.9%) |
Sep 2022 | - | $5.72B(-6.0%) |
Jun 2022 | - | $6.08B(+0.6%) |
Mar 2022 | - | $6.05B(+2.8%) |
Dec 2021 | $25.12B(+44.3%) | $5.88B(+14.7%) |
Sep 2021 | - | $5.13B(+12.2%) |
Jun 2021 | - | $4.57B(+7.6%) |
Mar 2021 | - | $4.25B(-5.6%) |
Dec 2020 | $17.40B(-1.8%) | $4.50B(+5.0%) |
Sep 2020 | - | $4.29B(+4.5%) |
Jun 2020 | - | $4.10B(-1.3%) |
Mar 2020 | - | $4.16B(+8.7%) |
Dec 2019 | $17.73B(+6.5%) | $3.83B(-16.4%) |
Sep 2019 | - | $4.58B(+7.2%) |
Jun 2019 | - | $4.27B(+12.6%) |
Mar 2019 | - | $3.79B(-0.3%) |
Dec 2018 | $16.64B(+3.4%) | $3.80B(+2.5%) |
Sep 2018 | - | $3.71B(-5.3%) |
Jun 2018 | - | $3.92B(+4.4%) |
Mar 2018 | - | $3.75B(-18.5%) |
Dec 2017 | $16.09B(+5.2%) | $4.61B(+18.9%) |
Sep 2017 | - | $3.87B(+6.5%) |
Jun 2017 | - | $3.64B(+0.2%) |
Mar 2017 | - | $3.63B(+36.5%) |
Dec 2016 | $15.30B(-9.9%) | $2.66B(-27.4%) |
Sep 2016 | - | $3.67B(-15.1%) |
Jun 2016 | - | $4.32B(+8.5%) |
Mar 2016 | - | $3.98B(-4.6%) |
Dec 2015 | $17.00B(-7.2%) | $4.17B(+4.5%) |
Sep 2015 | - | $4.00B(-7.9%) |
Jun 2015 | - | $4.34B(+6.8%) |
Mar 2015 | - | $4.06B(-23.2%) |
Dec 2014 | $18.32B(+8.7%) | $5.29B(+19.5%) |
Sep 2014 | - | $4.42B(+5.8%) |
Jun 2014 | - | $4.18B(+9.4%) |
Mar 2014 | - | $3.82B(+43.4%) |
Dec 2013 | $16.85B(+14.6%) | $2.67B(-17.5%) |
Sep 2013 | - | $3.23B(-10.1%) |
Jun 2013 | - | $3.59B(+10.3%) |
Mar 2013 | - | $3.26B(-13.5%) |
Dec 2012 | $14.70B(-9.8%) | $3.77B(+7.1%) |
Sep 2012 | - | $3.52B(+3.5%) |
Jun 2012 | - | $3.40B(+1.5%) |
Mar 2012 | - | $3.35B(-26.4%) |
Dec 2011 | $16.29B(+6.3%) | $4.55B(+15.5%) |
Sep 2011 | - | $3.94B(-6.7%) |
Jun 2011 | - | $4.22B(+10.3%) |
Mar 2011 | - | $3.83B(+5.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $15.33B(-4.4%) | $3.62B(-12.8%) |
Sep 2010 | - | $4.15B(+18.8%) |
Jun 2010 | - | $3.49B(+1.5%) |
Mar 2010 | - | $3.44B(-30.3%) |
Dec 2009 | $16.04B(+1.1%) | $4.94B(+33.2%) |
Sep 2009 | - | $3.70B(-1.8%) |
Jun 2009 | - | $3.77B(+11.7%) |
Mar 2009 | - | $3.37B(-17.3%) |
Dec 2008 | $15.86B(+5.4%) | $4.08B(+11.5%) |
Sep 2008 | - | $3.66B(-11.9%) |
Jun 2008 | - | $4.15B(+4.0%) |
Mar 2008 | - | $3.99B(-33.0%) |
Dec 2007 | $15.05B(+18.5%) | $5.95B(+53.4%) |
Sep 2007 | - | $3.88B(-0.3%) |
Jun 2007 | - | $3.89B(+12.8%) |
Mar 2007 | - | $3.45B(-6.7%) |
Dec 2006 | $12.70B(+5.0%) | $3.70B(+15.7%) |
Sep 2006 | - | $3.19B(-2.3%) |
Jun 2006 | - | $3.27B(+8.3%) |
Mar 2006 | - | $3.02B(-9.4%) |
Dec 2005 | $12.09B(+3.5%) | $3.33B(+19.6%) |
Sep 2005 | - | $2.79B(-11.1%) |
Jun 2005 | - | $3.13B(+5.1%) |
Mar 2005 | - | $2.98B(-3.3%) |
Dec 2004 | $11.69B(+12.6%) | $3.08B(+7.7%) |
Sep 2004 | - | $2.86B(-10.3%) |
Jun 2004 | - | $3.19B(+2.1%) |
Mar 2004 | - | $3.13B(+27.7%) |
Dec 2003 | $10.38B(+11.4%) | $2.45B(-6.0%) |
Sep 2003 | - | $2.60B(+2.8%) |
Jun 2003 | - | $2.53B(+5.6%) |
Mar 2003 | - | $2.40B(+2.9%) |
Dec 2002 | $9.31B(+18.4%) | $2.33B(+9.9%) |
Sep 2002 | - | $2.12B(-36.7%) |
Jun 2002 | - | $3.35B(+71.4%) |
Mar 2002 | - | $1.96B(-11.5%) |
Dec 2001 | $7.87B(-42.3%) | $2.21B(+12.7%) |
Sep 2001 | - | $1.96B(-2.0%) |
Jun 2001 | - | $2.00B(+10.0%) |
Mar 2001 | - | $1.82B(+841.7%) |
Dec 2000 | $13.64B(+61.3%) | $193.00M(-90.6%) |
Sep 2000 | - | $2.06B(-16.0%) |
Jun 2000 | - | $2.45B(+30.8%) |
Mar 2000 | - | $1.87B(+8.5%) |
Dec 1999 | $8.46B(+23.3%) | $1.73B(-18.4%) |
Sep 1999 | - | $2.12B(-8.1%) |
Jun 1999 | - | $2.31B(+37.2%) |
Dec 1998 | $6.86B(+1.3%) | - |
Jun 1998 | - | $1.68B(+143.3%) |
Dec 1997 | $6.77B(-7.4%) | - |
Dec 1996 | $7.32B(+24.3%) | - |
Dec 1995 | $5.89B(+1.3%) | - |
Jun 1995 | - | $690.40M |
Dec 1994 | $5.81B(+4.7%) | - |
Dec 1993 | $5.55B(+9.0%) | - |
Dec 1992 | $5.09B(-16.3%) | - |
Dec 1991 | $6.08B(+0.7%) | - |
Dec 1990 | $6.04B | - |
FAQ
- What is AstraZeneca PLC annual total operating expenses?
- What is the all time high annual operating expenses for AstraZeneca PLC?
- What is AstraZeneca PLC annual operating expenses year-on-year change?
- What is AstraZeneca PLC quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AstraZeneca PLC?
- What is AstraZeneca PLC quarterly operating expenses year-on-year change?
What is AstraZeneca PLC annual total operating expenses?
The current annual operating expenses of AZN is $33.86B
What is the all time high annual operating expenses for AstraZeneca PLC?
AstraZeneca PLC all-time high annual total operating expenses is $33.86B
What is AstraZeneca PLC annual operating expenses year-on-year change?
Over the past year, AZN annual total operating expenses has changed by +$5.04B (+17.49%)
What is AstraZeneca PLC quarterly total operating expenses?
The current quarterly operating expenses of AZN is $7.54B
What is the all time high quarterly operating expenses for AstraZeneca PLC?
AstraZeneca PLC all-time high quarterly total operating expenses is $7.97B
What is AstraZeneca PLC quarterly operating expenses year-on-year change?
Over the past year, AZN quarterly total operating expenses has changed by +$588.21M (+8.46%)